MedPath

Physical Activity and ARTs

Phase 4
Conditions
Stable BMI
Obesity
Infertility
Registration Number
NCT01892111
Lead Sponsor
University of Modena and Reggio Emilia
Brief Summary

Obese women experience increased infertility rate and longer time to conception showing lower pregnancy and live-birth rates both in natural and assisted conceptions. Body weight loss improves not only spontaneous pregnancy rates but also those of assisted reproductive techniques (ARTs). Almost all studies refer to body weight loss due to lifestyle intervention programs consisting in hypocaloric diet and increased physical activity, whereas very little is known about the specific effects of physical activity alone on human reproduction.

In a previous retrospective study, we demonstrated that physical activity enhances the reproductive performance of obese infertile patients who receive in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) cycles, regardless of body weight loss.

The aim of this randomized controlled trial (RCT) will be to evaluate if a structured exercise program improve the effectiveness of ARTs.

Detailed Description

Women with primary infertility scheduled to an IVF/ICSI procedure, obese and with a stable BMI will be randomized to receive a structured exercise program or nothing.

Patients will undergo a gonadotropin ovarian hyperstimulation for standard IVF/ICSI procedure.

clinical and biological data will be evaluated in each subject.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • infertility
  • obesity
  • stable BMI
  • schedule for ARTs
Exclusion Criteria
  • use of cryopreserved embryos
  • any changes in diet and physical activity
  • tobacco smoking
  • drug use
  • alcohol abuse
  • uterine diseases
  • previous pelvic surgery
  • major medical diseases
  • clinical history of (or suspicion of) endometriosis, antiphospholipid antibody syndrome, recurrent miscarriage
  • obese partner
  • severe sperm pathology

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
pregnancy rate.4 months
Secondary Outcome Measures
NameTimeMethod
implantation rate1 month
cancellation rate1 months
miscarriage rate4 months
stimulation lenght and dose1 month
embryo transferred1 month
multiple pregnancy rate4 months
OHSS rate1 month

Trial Locations

Locations (1)

Unit of Gynecology & Obstetrics - Arcispedale S. Maria Nuova of Reggio Emilia, IRCCS, University of Modena and Reggio Emilia

🇮🇹

Reggio Emilia, Italy

Unit of Gynecology & Obstetrics - Arcispedale S. Maria Nuova of Reggio Emilia, IRCCS, University of Modena and Reggio Emilia
🇮🇹Reggio Emilia, Italy
Stefano Palomba, MD
Principal Investigator
Angela Falbo, MD
Sub Investigator
Giovanni B La Sala, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.